Efficacy and Safety of Actovegin 12-Week Treatment IV then Oral in Peripheral Arterial Occlusive Disease Fontaine Stage IIB
Peripheral Arterial Diseases
Enrolment: 366 · Results not recorded
Loading the evidence…
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Peripheral Arterial Diseases
Enrolment: 366 · Results not recorded
Symptomatic Diabetic Peripheral Polyneuropathy
Enrolment: 569 · Results not recorded
Post-Stroke Cognitive Impairment (PSCI)
Enrolment: 503 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute liver injury induced by 10 per cent carbon tetrachloride in blend oil at 10 mL/kg, given 2 hours after the last treatment dose; control animals received blend oil alone
DECB reduced serum ALT (33.01 plus or minus 5.86 versus 56.46 plus or minus 11.30 IU/L) and AST (65.34 plus or minus 15.39 versus 97.73 plus or minus 9.33 IU/L) relative to the model group, lowered MDA and the hepatocyte apoptosis index (2.89 plus or minus 0.55 per cent versus 6.09 plus or minus 0.…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.